2024
DOI: 10.1038/s41598-024-55656-8
|View full text |Cite
|
Sign up to set email alerts
|

Electroencephalography-based classification of Alzheimer’s disease spectrum during computer-based cognitive testing

Seul-Kee Kim,
Hayom Kim,
Sang Hee Kim
et al.

Abstract: Alzheimer’s disease (AD) is a progressive disease leading to cognitive decline, and to prevent it, researchers seek to diagnose mild cognitive impairment (MCI) early. Particularly, non-amnestic MCI (naMCI) is often mistaken for normal aging as the representative symptom of AD, memory decline, is absent. Subjective cognitive decline (SCD), an intermediate step between normal aging and MCI, is crucial for prediction or early detection of MCI, which determines the presence of AD spectrum pathology. We developed a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…MCI serves as a critical transitional stage between normal aging and dementia. Diagnosis involves clinical observation (Rodriguez-Santiago et al, 2024 ), neuroimaging (Chouliaras and O'Brien, 2023 ), biomarkers (An et al, 2024 ; Carpi et al, 2024 ; Kim S. et al, 2024 ; Kim S. K. et al, 2024 ; Perneczky et al, 2024 ; Plassman et al, 2024 ; Wu et al, 2024 ; Zuo et al, 2024 ), and electroencephalography (EEG) (Amato et al, 2024 ; Faghfouri et al, 2024 ; Khatun et al, 2024 ; Rutkowski et al, 2024 ; Sun et al, 2024 ), as well as neuropsychological assessments.…”
Section: Basic Overview Of the Diagnosis And Therapeutic Of MCImentioning
confidence: 99%
“…MCI serves as a critical transitional stage between normal aging and dementia. Diagnosis involves clinical observation (Rodriguez-Santiago et al, 2024 ), neuroimaging (Chouliaras and O'Brien, 2023 ), biomarkers (An et al, 2024 ; Carpi et al, 2024 ; Kim S. et al, 2024 ; Kim S. K. et al, 2024 ; Perneczky et al, 2024 ; Plassman et al, 2024 ; Wu et al, 2024 ; Zuo et al, 2024 ), and electroencephalography (EEG) (Amato et al, 2024 ; Faghfouri et al, 2024 ; Khatun et al, 2024 ; Rutkowski et al, 2024 ; Sun et al, 2024 ), as well as neuropsychological assessments.…”
Section: Basic Overview Of the Diagnosis And Therapeutic Of MCImentioning
confidence: 99%